Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeNON PROFITJVIR, SIR Foundation Honor Best Research Published in 2019

JVIR, SIR Foundation Honor Best Research Published in 2019

The Journal of Vascular and Interventional Radiology (JVIR)—the Society of Interventional Radiology’s (SIR’s) peer-reviewed scientific journal—announced the 2019 JVIR Editor’s Best awards in the May issue of the journal, published online today. The annual awards, supported by SIR Foundation, were chosen by the editor after a comprehensive editorial board review of all papers submitted to JVIR during the prior year.

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING CLINICAL STUDY

Belinda A. Mohr, Ph.D., was honored with the award for outstanding clinical research paper for “Clinical and Economic Benefits of Stent Grafts in Dysfunctional and Thrombosed Hemodialysis Access Graft Circuits in the REVISE Randomized Trial.”

In citing why this paper stood out, JVIR Editor-in-chief Ziv J Haskal, M.D., FSIR, said, “The analysis adds to the growing base of rigorous economic assessments of our interventional therapies. Hemodialysis costs billions of dollars in America. Our growing number of prospective controlled IR-led trials, such as in end-stage renal disease, allow this very type of essential research to help define the societal value of interventions for our patients.”

2019 JVIR EDITOR’S AWARD FOR OUTSTANDING LABORATORY INVESTIGATION

Yuchen Huo, MA, of the University of California San Diego, was honored with the award for outstanding laboratory investigation for “Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.”

“The downstream immunologic effects of thermal and transcatheter oncological treatments are being methodically fleshed out in the IR literature,” said Haskal. “One aspect is the under-recognized potential stimulatory effect of locoregional HCC treatments which might risk promulgating HCC stem cell proliferation, lessening overall cancer outcomes. This study described and quantified this very effect and defined a pathway for potentially suppressing it.”

Haskal, a professor with the department of radiology and medical imaging at the University of Virginia Health System in Charlottesville, also recognized the authors of an additional 12 clinical and five laboratory papers for their contributions. “In my decade as editor, this year marked a remarkably rich and diverse one for interventional radiologic research,” noted Haskal.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy